PUBLISHER: Grand View Research | PRODUCT CODE: 1631544
PUBLISHER: Grand View Research | PRODUCT CODE: 1631544
The global capillary blood collection devices market size is expected to reach USD 3.52 billion by 2030, registering a CAGR of 8.8% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing incidence of chronic, infectious, and autoimmune diseases are some of the major factors propelling market growth owing to the rising number of blood tests globally. Capillary blood draw technique has been most widely used for glucose and hemoglobin testing in clinics and hospitals. Ease of usage and minimally invasive nature also makes it ideal for home care diagnosis and testing, thereby boosting the market's growth potential. The use of this technique in conjugation with PoC diagnostics has become the chosen mode of testing in remote and ambulatory health settings.
Blood gas detection, leukocyte & metabolite count, biomarker, nucleic acid, blood glucose, ferritin, lactate, effect of vitamin K-antagonist, and heavy metal ions analysis is commonly done using these samples. Thus, with the rising adoption of rapid PoC diagnostics, the usage of these devices is anticipated to increase in the near future.
Chronic diseases are a global healthcare problem with over half of the adult population in the U.S. suffering from chronic diseases, which contribute to over 75% of the total healthcare cost in the nation. Thus, the rising number of infectious and chronic diseases creates a huge demand for diagnostic testing, thereby propelling the growth of these collection devices.
Capillary blood draw technique is most often used in the case of pediatric patients as it is difficult to draw venous and arterial blood from infants. Capillary blood draw is preferred in many ICU settings as patients lose a large amount of blood during surgeries. Other blood drawing techniques are more invasive and might result in delays in the healing process or pose a risk of contamination. Ease of usage and effectiveness is another factor facilitating the use of these devices for home care diagnosis and testing, typically in case of diabetics.